Question special
Resident

The subject of proning to increase oxygenation of atelectatic lung areas has been studied in the PROSEVA trial mentioned earlier in the discussion. This study also recommends the use of early NM blockade in severe ARDS patients. The recent ROSE trial stated there no mortality benefit and even potential cardiovascular harm to those receiving early NM blockade. Did you notice any difference in use between the two arms? I'm wondering if early NM blockade may show benefit in some select scenarios.